RxDoctor Payments DataLook up a doctor →

Frank Marino, DO

Family Medicine · Sioux City, IANPI 1699740159

Payments from drug & device makers

$8,030in general payments, 2019–2025

Across 577 payments — averaging $13.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Amgen$889
  • AstraZeneca$680
  • Pfizer$568
  • Lilly USA, LLC$514
  • Merck$416
  • plus $4K from 48 others

What the payments were for

  • Food & beverage$7,991100%
  • Education$400%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,030 in reported general payments places this provider in the 95th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$247,698
Medicare patients
363
Services billed
14,620

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban137$90,350
OzempicSemaglutide67$75,347
FarxigaDapagliflozin Propanediol63$51,844
MounjaroTirzepatide29$36,686
Breo ElliptaFluticasone/Vilanterol58$30,248
JanuviaSitagliptin Phosphate23$23,858
JardianceEmpagliflozin24$23,765
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$23,331
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog14$18,431
Novolog FlexpenInsulin Aspart16$5,821
Fluticasone-SalmeterolFluticasone Propion/Salmeterol11$3,745
Gabapentin169$3,510
Atorvastatin Calcium381$3,226
Omeprazole323$3,168
Levothyroxine Sodium465$2,979

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$568$90,350137 claims
Novo NordiskOzempic$1,121$75,34767 claims
AstraZenecaFarxiga, Symbicort$680$54,68077 claims
GSKBreo Ellipta, Trelegy Ellipta$232$53,57886 claims
Lilly USA, LLCMounjaro$514$36,68629 claims
MerckJanuvia$416$23,85823 claims
Boehringer IngelheimJardiance$299$23,76524 claims
AbbVieSynthroid$292$1,71520 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in Sioux City

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →